comparemela.com

Ian Estepan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript

SRPT earnings call for the period ending March 31, 2024.

United statesIan estepanMary jenkinsDoug ingramNicole verdunPeter marksLouise rodino klapacCorporate communicationsExchange commissionSarepta therapeuticsInvestor relationsDallan murrayChief executiveSarepta therapeutic

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomIan estepanSarepta therapeutics incCompensation committeeCommencement incentive planNasdaq listing ruleGrant datePrecision genetic medicine engineFor investor

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDoug ingramIan estepanExchange agreementsBiomarin pharmaceuticals incRoche ltdTrademark officeExchange commissionDrug administrationUniversity of western australiaSarepta therapeutics incThermo fisher scientific incRecent developmentsBiologics license applicationPriority review

Sarepta Therapeutics (SRPT) Q4 2023 Earnings Call Transcript

SRPT earnings call for the period ending December 31, 2023.

United statesKristen kluskaDanielle brillGil blum needhamTazeen ahmadBrian skorneyDavid hoangGil blumGena wangWilliam blairKostas biliourisDavid hoang citiIan estepanBrian abrahamsMille cantor fitzgeraldLouise rodino klapac

Sarepta Therapeutics, Inc (NASDAQ:SRPT) Q4 2023 Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2023 Earnings Call Transcript February 28, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.47, expectations were $-0.03. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]

United statesIan estepanLouise rodino klapacDouglas ingramSpeak foundationChief scientific officerDoctors marksNature medicine

vimarsana © 2020. All Rights Reserved.